Search Results - "Viero, Piera"
-
1
Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
Published in The New England journal of medicine (22-10-2020)“…In patients who have acute lymphoblastic leukemia with tumor cells that bear the Philadelphia chromosome, traditional therapy is not very effective. The use of…”
Get full text
Journal Article -
2
Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells
Published in Mediterranean journal of hematology and infectious diseases (2015)“…The introduction of newer cytotoxic monoclonal antibodies and chimeric antigen receptor modified T cells is opening a new age in the management of B-lineage…”
Get full text
Journal Article -
3
Prognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemia
Published in Mediterranean journal of hematology and infectious diseases (01-01-2014)“…Acute lymphoblastic leukemia (ALL) is curable in about 40-50% of adult patients, however this is subject to ample variations owing to several host- and…”
Get full text
Journal Article -
4
Risk of Second Cancer in Nongastric Marginal Zone B-Cell Lymphomas of Mucosa-Associated Lymphoid Tissue: A Population-Based Study from Northern Italy
Published in Clinical cancer research (01-01-2007)“…Purpose: The aim of this study was to define the risk of second cancer in nongastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT)…”
Get full text
Journal Article -
5
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
Published in Journal of clinical oncology (10-02-2018)“…Purpose To investigate the progression-free survival (PFS) of patients with advanced Hodgkin lymphoma (HL) after a risk-adapted treatment strategy that was…”
Get full text
Journal Article -
6
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
Published in Journal of clinical oncology (20-11-2020)“…To investigate the role of consolidation radiotherapy (cRT) in advanced-stage Hodgkin lymphoma (HL) presenting at baseline with a large nodal mass (LNM) in…”
Get full text
Journal Article -
7
Current and future management of Ph/BCR-ABL positive ALL
Published in Expert review of anticancer therapy (01-06-2014)“…Following the introduction of targeted therapy with tyrosine kinase inhibitors (TKI) at the beginning of the past decade, the outcome of patients with…”
Get full text
Journal Article -
8
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL
Published in Cancers (27-04-2021)“…In many clinical studies published over the past 20 years, adolescents and young adults (AYA) with Philadelphia chromosome negative acute lymphoblastic…”
Get full text
Journal Article -
9
Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia
Published in Clinical lymphoma, myeloma and leukemia (01-07-2017)“…The study of minimal residual disease (MRD) in adult patients with acute lymphoblastic leukemia (ALL) allows a greater refinement of the individual risk…”
Get full text
Journal Article -
10
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)
Published in Hematological oncology (01-10-2022)“…Salvage immunochemotherapy and transplant consolidation is the standard treatment for relapsed or refractory (R/R) diffuse large B‐cell lymphoma (DLBCL). We…”
Get full text
Journal Article -
11
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) and Lymphocyte to Monocyte Ratio (LMR) in Newly Diagnosed Advanced-Stage Hodgkin Lymphoma Patients Treated up-Front with a PET-2 Risk Adapted Protocol
Published in Blood (29-11-2018)“…Background: Hodgkin Lymphoma (HL) is characterized by an inflammatory background and it has been demonstratedthat the reactive myeloid cells may exert an…”
Get full text
Journal Article -
12
Burkitt lymphoma in adolescents and young adults: management challenges
Published in Adolescent health, medicine and therapeutics (01-01-2017)“…About one-half of all Burkitt lymphoma (BL) patients are younger than 40 years, and one-third belong to the adolescent and young adult (AYA) subset, defined by…”
Get full text
Journal Article -
13
OBINUTUZUMAB DOES NOT IMPROVE COMPLETE METHABOLIC RESPONSE BUT DOES NOT COMPROMISE MOBILIZATION OR ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN DIFFUSE LARGE B CELL LYMPHOMA: RESULTS FROM A FIL PROSPECTIVE PHASE II STUDY (THE GIOTTO STUDY)
Published in Hematological oncology (25-05-2022)“…Salvage immunochemotherapy and transplant consolidation is the standard treatment for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL). We…”
Get full text
Journal Article -
14
Global Phase I/III Pharmacokinetic and Efficacy Study Comparing CT-P10, a Biosimilar Candidate to the Rituximab Reference Product in Patients with Advanced Stage Follicular Lymphoma (AFL)
Published in Blood (03-12-2015)“…Global phase I/III pharmacokinetic and efficacy study comparing CT-P10, a biosimilar candidate to the rituximab reference product in patients with advanced…”
Get full text
Journal Article -
15
The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET‐2‐adapted HD0607 trial
Published in Cancer medicine (Malden, MA) (01-12-2020)“…Background The neutrophil to lymphocyte ratio (NLR) and the lymphocyte to monocyte ratio (LMR) can reflect both the myeloid dysfunction and T‐cell immune…”
Get full text
Journal Article -
16
Lymphomas occurring late after solid-organ transplantation: Influence of treatment on the clinical outcome
Published in Transplantation (27-10-2002)“…Posttransplant lymphoproliferative disorders (PTLDs) that occur late after solid-organ transplantation are usually a monoclonal proliferation frequently…”
Get full text
Journal Article -
17
The management of acute myelogenous leukemia in the elderly: ten-year experience in 118 patients
Published in Hematological oncology (01-09-1992)“…This retrospective study was undertaken to analyse the survival pattern of 118 consecutive, unselected patients with acute myelogenous leukemia (AML) aged…”
Get more information
Journal Article -
18
Multicentric Clinical Audit of Chemotherapy Administration for Lymphoprolipherative Diseases in Day Hospital Patient Setting
Published in Blood (16-11-2008)“…Introduction Chemotherapy (CHT) administration is a high risk process. In particular, in the Day Hospital (DH) patient setting, the potential toxicity of…”
Get full text
Journal Article -
19
The Addition of Rituximab to High Dose Sequential Chemotherapy (HDS) Programs with Autologous Transplantation Significantly Improves the Outcome of Patients with Refractory or Relapsed B-Cell Non Hogkin's Lymphoma
Published in Blood (16-11-2005)“…The aim of the present study was to evaluate retrospectively the clinical outcome of 2 consecutive cohorts of relapsed/refractory NHL patients treated with HDS…”
Get full text
Journal Article -
20
High Risk of Severe Bleeding in Aged Patients With Chronic Idiopathic Thrombocytopenic Purpura
Published in Blood (01-01-1991)“…The purpose of this study was to estimate the incidence and to establish which factors were associated with an increased risk of hemorrhagic complications in…”
Get full text
Journal Article